IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Saturday, 26 December 2015

Start-up unicorns: does IP matter?

›
Surely one of the more colorful terms in the world of start-ups is the word "unicorn." As most readers are probably aware, in ...
1 comment:
Thursday, 24 December 2015

Regulation over Markets (or More Regulation on Regulation): California’s Initiative on Pharmaceutical Pricing

›
In California, there are basically at least two ways to create a law.   The first is the traditional route through the legislature with th...
Tuesday, 22 December 2015

Patents and Share Prices - Ericsson

›
Apple and Ericsson have been engaged in a number of patent infringement suits over the past few years. Finally, on Monday Ericsson announc...
1 comment:
Saturday, 19 December 2015

Philip Morris claim against Australia for Tobacco Plain Packaging Dismissed

›
The issue of plain packaging for tobacco is a controversial one, which not only has the obvious public health issues, but an additional di...
1 comment:
Friday, 18 December 2015

More than just money: a primer on reverse payment settlements

›
IP Finance is delighted to publish the following post by Teemu Alexander Puutio , an expert in the analysis and valuation of intellectual ...

How to Create an Excellent Innovation Outpost

›
Start-up guru and Lean Launchpad developer Steve Blank has published a fascinating set of four blog posts on Innovation Outposts with co-...
Wednesday, 16 December 2015

A Very Good Resource on the Bayh-Dole Act and Commercialization

›
In the last few weeks, I have had the opportunity to refer folks to a book on the Bayh-Dole Act and technology transfer.   The excellent b...
Saturday, 12 December 2015

The Coming Increased Transparency in Pharmaceutical Pricing in the United States?

›
Pharmaceutical pricing has been viewed as a black box type of affair.   However, a recent Wall Street Journal article authored by Jonathan D...
Monday, 7 December 2015

Google’s Patent Purchase Program: What Did We Learn?

›
Recently, this blog discussed Google’s Patent Purchase Program (Program), here .   The Program was designed to help Google get in front of...
‹
›
Home
View web version
Powered by Blogger.